Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 216 participants.

Also called NCT06945809

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 216 participants (planned count) (from the registry)
Sponsor
Hangzhou Endonom Medtech Co., Ltd. (from the registry)
Registry
  • NCT NCT06945809
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06945809. Randomized; no masking; primary purpose treatment. Start 2026-07-13 (actual); primary completion 2028-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
Acronym
Gallant
Condition
Distal Entry Tear
Intervention (Device)
WeFlow-EndoPatch Aortic Endovascular Patch System
Intervention (Other)
Conventional Treatment group
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06945809
Content hash
0a1044c33be4b4e9c13b3f041d656930a6c1aea79ed5a51b2ac6f560d61f4ab1